Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Maria Maccecchini, PhD$117M
Market Cap • 25/07/20242008
(há 16 anos)
2020
(4 years ago)
NYSE
Listagem
Malvern
Sede • Pennsylvania5
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ANVSSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.